Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPhoenix Group Holdings Regulatory News (PHNX)

  • There is currently no data for PHNX

Directorate Change

25 Jun 2018 07:03

RNS Number : 3043S
Standard Life Aberdeen plc
22 June 2018
 

Standard Life Aberdeen plc

 

Board change

 

The Board of Standard Life Aberdeen plc ('SLA') announces that Cathleen Raffaeli will be appointed as a Non-Executive Director with effect from 1 August 2018.

 

Commenting on her appointment, Sir Gerry Grimstone, Chairman of SLA, said:

 

"I am delighted that Cathi has agreed to join our Board. Her strong FinTech experience and background in the platforms sector, as well as her board experience, make her an ideal addition as we continue to build a world class investment company".

 

At the same time as she joins the Board, Cathleen Raffaeli will be appointed as a member of the Remuneration Committee.

 

Following this appointment, the Board will comprise four executive directors, nine non-executive directors and the Chairman. The Board will be made up of three women and eleven men. The restructuring of the Board after the merger in 2017 will continue over the coming months. The Financial Conduct Authority and the Prudential Regulation Authority have been notified of this appointment. Cathleen Raffaeli's other appointments are listed below and no other information is required to be disclosed pursuant to paragraph LR 9.6.13R of the Listing Rules of the Financial Conduct Authority.

 

The Board also notes the announcement this morning by the Board of Phoenix Group Holdings ('PGH') of the proposed appointment of Barry O'Dwyer and Campbell Fleming as Non-Executive Directors of PGH. These appointments will be effective from the date of completion of the acquisition by Phoenix Group of SLA's UK and European insurance business and are being made pursuant to nomination by SLA in accordance with the terms of its contractual arrangements with PGH.

 

Barry O'Dwyer is the CEO of SLA's Pensions & Savings business (Standard Life). Barry has held several senior roles at Standard Life since re-joining the company in 2013, and during his initial spell at Standard Life between 1988-2008. A fellow of the Institute of Actuaries, Barry has 30 years of experience in the insurance industry, in a career which has also included senior roles at Prudential and HBOS.

 

Campbell Fleming is the Global Head of Distribution at Aberdeen Standard Investments, the asset management business of SLA. He joined Aberdeen Asset Management in August 2016 from Columbia Threadneedle Investments where he was the Chief Executive - EMEA and Global COO. Campbell is the Chair of the Investment Association Trade Committee and previously held senior positions at JP Morgan Asset Management.

 

25 June 2018

Enquiries:

Media: Katy Hetherington

+44 (0) 131 245 2283*

+44 (0) 7841 344 374

 

Institutional Equity Investors: Jakub Rosochowski

+44 (0) 131 245 8028*

+44 (0) 7515 298 608

 

Group Secretariat: Paul McKenna

+44 (0) 131 245 1168*

 

 

* Calls may be monitored and/or recorded to protect both you and us and help with our training. Call charges will vary.

 

END

 

LEI number of Standard Life Aberdeen plc: 0TMBS544NMO7GLCE7H90

Classification: 3.1. Additional regulated information required to be disclosed under the laws of a Member State

 

 

Notes to Editors

 

Cathleen Raffaeli

 

Non-Executive Director's Fee

 

Cathleen Raffaeli's fee as a Non-Executive Director of SLA will be £73,500 per annum.

 

Interest in shares

 

As at the date of her appointment, Cathleen Raffaeli does not hold any shares in Standard Life Aberdeen plc.

 

Biographical details:

Nationality:

American

Education/Qualifications:

New York University, MBA (1988)

University of Baltimore, BS, (1979)

Other Non-Executive Appointments:

2007 - Present

Federal Home Loan Bank of New York

Non-Executive Director

Previous Non-Executive and Advisory Roles:

2014-2016

2003-2011

1998-2008

Kapitall Holdings

 

E\* Trade Financial

 

American Home Mortgage Investment

Career summary:

2002-Present

Hamilton White Group and Soho Venture Partners

Managing Partner

2000-2002

ProAct Technologies

President and Chief Executive Officer

1998-2000

CFN

Chief Executive Officer

1994-1998

Citicorp

Various commercial, transaction and mortgage roles

1988-1994

Chemical Bank

Various commercial, transaction and mortgage roles

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAPGUPGQUPRGAP
Date   Source Headline
14th Mar 20259:00 amRNSBoard Change
6th Mar 20253:35 pmRNSDirector/PDMR Shareholding
3rd Mar 202511:12 amRNSTotal Voting Rights
6th Feb 20254:12 pmRNSDirector/PDMR Shareholding
5th Feb 20255:41 pmRNSCompletion of Early Redemption
3rd Feb 20255:47 pmRNSTotal Voting Rights
7th Jan 20252:19 pmRNSDirector/PDMR Shareholding
2nd Jan 202511:00 amRNSTotal Voting Rights
2nd Jan 20258:30 amRNSAnnouncement of Early Redemption
12th Dec 20244:35 pmRNSBlock Listing Application
12th Dec 20244:11 pmRNSBlock listing Return
6th Dec 20245:39 pmRNSDirector/PDMR Shareholding
4th Dec 20249:00 amRNSDirectorate Change
2nd Dec 20241:32 pmRNSTotal Voting Rights
6th Nov 20245:48 pmRNSDirector/PDMR Shareholding
6th Nov 20247:00 amRNSDirectorate Change
5th Nov 20249:22 amRNSDirector/PDMR Shareholding
1st Nov 202412:48 pmRNSDirector/PDMR Shareholding
1st Nov 202412:43 pmRNSTotal Voting Rights
22nd Oct 20244:19 pmRNSDirector/PDMR Shareholding
8th Oct 20245:24 pmRNSDirector/PDMR Shareholding
4th Oct 20243:35 pmRNSDirector/PDMR Shareholding
1st Oct 202410:56 amRNSTotal Voting Rights
18th Sep 202410:56 amRNSDirector/PDMR Shareholding
17th Sep 202411:09 amRNSDirector/PDMR Shareholding
16th Sep 20247:00 amRNS2024 Interim Results
10th Sep 20243:54 pmRNSDirector/PDMR Shareholding
6th Sep 20248:58 amRNSMajor Shareholding
2nd Sep 202411:08 amRNSTotal Voting Rights
28th Aug 20249:16 amRNSDirectorate Change
6th Aug 20245:02 pmRNSDirector/PDMR Shareholding
1st Aug 20241:28 pmRNSTotal Voting Rights
8th Jul 20245:44 pmRNSDirector/PDMR Shareholding
1st Jul 20244:32 pmRNSTotal Voting Rights
26th Jun 20247:00 amRNSPhoenix Group to explore the sale of SunLife
20th Jun 20247:00 amRNSDeleveraging Programme Update
14th Jun 20248:14 amRNSResult of Tender Offer
11th Jun 20241:51 pmRNSBlock listing Return
10th Jun 20244:15 pmRNSPublication of Offering Memorandum
6th Jun 20245:14 pmRNSDirector/PDMR Shareholding
6th Jun 20242:11 pmRNSIssue of debt and tender maximum acceptance amount
5th Jun 20247:29 amRNSTender Offers and New Issue
3rd Jun 20241:27 pmRNSTotal Voting Rights
24th May 202411:05 amRNSDirector/PDMR Shareholding
14th May 20242:43 pmRNSResult of AGM
13th May 20247:00 amRNSDirectorate Change
8th May 20244:33 pmRNSDirector/PDMR Shareholding
3rd May 202411:04 amRNSAnnouncement of Early Redemption
1st May 202411:23 amRNSTotal Voting Rights
12th Apr 20244:41 pmRNSSupplemental Circular to the 2024 Notice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.